CCR7 and neoplasm: In a study of inflammatory breast cancer, immunohistochemical analysis of receptor paraffin-embedded tumor tissue sections revealed that ~23% of inflammatory breast cancer samples were positive for CCR7, which correlated with a decreased 5 year overall survival for CCR7-positive patients (20%) versus 41.9% for CCR7-negative patients [55].